TATVA

Tatva Chintan Pharma Chem Share PriceTatva Chintan Pharma Chem

₹1637.6
16.95 (1.05%)
As on 30 March, 2023 | 09:50 BSE: 543321 NSE: TATVA

Tatva Chintan Pharma Chem Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Tatva Chintan Pharma Chem

Start SIP

Tatva Chintan Pharma Chem Share Price

  • Over 1 Month -14.55%
  • Over 3 Month -23.4%
  • Over 6 Month -34.6%
  • Over 1 Year -25.83%

Tatva Chintan Pharma Chem Key Statistics

P/E Ratio 78.8
PEG Ratio -1.5
Market Cap Cr 3,630
Price to Book Ratio 7.7
EPS 43.3
Dividend 0.1
Relative Strength Index 18.51
Money Flow Index 24.86
MACD Signal -70.51
Average True Range 45.73

Tatva Chintan Pharma Chem Investment Rating

  • Master Rating:
  • Tatva Chintan Pharma Chem has an operating revenue of Rs. 397.63 Cr. on a trailing 12-month basis. An annual revenue growth of 44% is outstanding, Pre-tax margin of 24% is great, ROE of 20% is exceptional. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 18 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 51 indicates it belongs to a fair industry group of Chemicals-Basic and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Tatva Chintan Pharma Chem Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1148486102
Operating Expenses Qtr Cr 97757380
Operating Profit Qtr Cr 1791322
Depreciation Qtr Cr 2222
Interest Qtr Cr 2111
Tax Qtr Cr 3231
Net Profit Qtr Cr 115919

Tatva Chintan Pharma Chem Technicals

EMA & SMA

Current Price
₹1637.6
16.95 (1.05%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 1770.1
  • 50 Day
  • 1900.82
  • 100 Day
  • 2034.82
  • 200 Day
  • 2160.63
  • 20 Day
  • 1785.2
  • 50 Day
  • 1930.65
  • 100 Day
  • 2082.1
  • 200 Day
  • 2238.97

Tatva Chintan Pharma Chem Resistance and Support

PIVOT
₹1629.22
Resistance
First Resistance 1657.44
Second Resistance 1694.22
Third Resistance 1722.44
RSI 18.52
MFI 24.86
MACD Single Line -70.51
MACD -80.86
Support
First Resistance 1592.44
Second Resistance 1564.22
Third Resistance 1527.44

Tatva Chintan Pharma Chem Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 23,256 1,804,200 77.58
Week 11,410 873,778 76.58
1 Month 9,706 726,415 74.84
6 Month 10,013 671,144 67.03

Tatva Chintan Pharma Chem Result Highlights

Tatva Chintan Pharma Chem Synopsis

NSE-Chemicals-Basic

Tatva Chintan Pharm is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 427.81 Cr. and Equity Capital is Rs. 22.17 Cr. for the Year ended 31/03/2022. Tatva Chintan Pharma Chem Ltd. is a Public Limited Listed company incorporated on 12/06/1996 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ1996PLC029894 and registration number is 029894.
Market Cap 3,630
Sales 386
Shares in Float 0.47
No of funds 31
Yield 0.12
Book Value 7.74
U/D Vol ratio 0.5
LTDebt / Equity 3
Alpha -0.11
Beta 0.8

Tatva Chintan Pharma Chem

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 79.17%79.17%79.17%
Mutual Funds 11.12%10.8%10.34%
Insurance Companies 0.2%0.17%0.22%
Foreign Portfolio Investors 3.74%3.59%3.53%
Individual Investors 5.01%5.49%6.03%
Others 0.76%0.78%0.71%

Tatva Chintan Pharma Chem Management

Name Designation
Mr. Chintan Nitinkumar Shah Chairman & Managing Director
Mr. Ajaykumar Mansukhlal Patel Whole Time Director
Mr. Shekhar Rasiklal Somani Whole Time Director
Dr. Manher Chimanlal Desai Independent Director
Mr. Subhash Ambubhai Patel Independent Director
Dr. Avani Rajesh Umatt Independent Director

Tatva Chintan Pharma Chem Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Tatva Chintan Pharma Chem MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 23910
Nippon India Tax Saver (ELSS) Fund - Growth 11211
Axis Flexi Cap Fund Regular Growth 10077
SBI Magnum Midcap Fund Regular Growth 8436
Mirae Asset Hybrid Equity Fund -Regular Plan-Growth 6953

Tatva Chintan Pharma Chem FAQs

What is Share Price of Tatva Chintan Pharma Chem ?

Tatva Chintan Pharma Chem share price is ₹1637 As on 30 March, 2023 | 09:36

What is the Market Cap of Tatva Chintan Pharma Chem ?

The Market Cap of Tatva Chintan Pharma Chem is ₹3629.8 Cr As on 30 March, 2023 | 09:36

What is the P/E ratio of Tatva Chintan Pharma Chem ?

The P/E ratio of Tatva Chintan Pharma Chem is 78.8 As on 30 March, 2023 | 09:36

What is the PB ratio of Tatva Chintan Pharma Chem ?

The PB ratio of Tatva Chintan Pharma Chem is 7.7 As on 30 March, 2023 | 09:36

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number